Stopped: The sponsor decided to withdraw the study.
The study purpose is to determine if thymus tissue cultured in a serum-free (SF) solution is a safe and effective treatment for atypical and typical complete DiGeorge anomaly. \[Funding Source - FDA OOPD\]
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Survival
Timeframe: One year post-thymus transplantation.
Incidence of graft-versus-host-disease (GVHD).
Timeframe: One year post-thymus-transplantation.
Thymopoiesis or graft rejection on biopsy.
Timeframe: Two months post-thymus transplantation.